Uniphar | Clinical published a guide from Uniphar | Development sharing practical insights to help sponsors master FDA engagement and keep programs progressing.
Public source
Publisher name
Public post
Beyond keeping clinical trials supplied and on track, Uniphar also guides sponsors through the regulatory strategy that moves programs forward. This guide from our colle…
Company
Uniphar | Clinical
- Industry
- Pharmaceutical Manufacturing
- Location
- Garner, US
- Company size
- 2–10 employees
About Uniphar | Clinical
Uniphar is a trusted global partner to pharma, medtech and biotech, delivering solutions that connect medicines and technologies with patients worldwide. With over 57 years of experience and partnerships with 200+ multinational clients, Uniphar combines deep expertise, global infrastructure and market insight to meet the evolving needs of the life sciences sector. Uniphar | Clinical is part of the Uniphar Pharma division. Uniphar Pharma integrates Development, Clinical, Access, Medical, Commercial, Distribution and Global Sourcing to support the full product lifecycle – from early-stage research through to commercialization and beyond. Uniphar | Clinical accelerates clinical trials by delivering agile, end-to-end clinical supply solutions across the globe. Backed by decades of expertise and cutting-edge technology, we support pharmaceutical, biotech, and medical device companies with comparator sourcing, packaging and labeling, global distribution, and controlled drug services. With facilities in the US and EU and a commitment to quality, flexibility, and patient-first thinking, we help bring breakthrough treatments to market—faster. Uniphar’s unified platform spans regulatory strategy, clinical trial support, medical affairs, market access, patient engagement, commercial services, distribution and supply chain. Operating across 180 countries with a global team of 3,500+, Uniphar bridges manufacturers, healthcare providers, and patients — accelerating access to innovative therapies, improving patient outcomes, and delivering value across the healthcare ecosystem. From molecule to market and beyond.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Uniphar | Medical
Uniphar | Medical published a guide for sponsors navigating the science and strategy of drug development, including through the FDA.
Research & Knowledge
Uniphar | Access
Uniphar | Access published a white paper titled From discovery to durable value: Why advanced therapies need integrated planning across development, investment, evidence generation, and access.
Research & Knowledge
BAP Pharma
BAP Pharma published a case study detailing how the company helped a sponsor overcome increased demand, compressed packaging timelines, procurement constraints, and product waste risk through an agile comparator sourcing strategy.
Research & Knowledge
Parexel
Parexel published an analysis in the New Medicines, Novel Insights newsletter examining the changes introduced by the FDA's proposed PDUFA VIII commitment letter, including earlier FDA engagement, greater focus on CMC readiness, and expanded meeting opportunities.
Research & Knowledge
Alcura